Assessment of antiplatelet resistance in post-angioplasty patients (THE ANTI-PLATELET RESISTANCE STUDY)
- Conditions
- Health Condition 1: null- The study will include adult patients (age 18 years) with newlydiagnosed CAD for which angioplasty is done with stents
- Registration Number
- CTRI/2018/01/011578
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. >=18 years of age, male, or female
2. Patients with newly diagnosed CAD for which coronary angioplasty is done with
stent (s)
3. Patients on dual antiplatelet therapy including aspirin and one of the P2Y12 inhibitors
i.e. clopidogrel, ticagrelor or prasugrel.
1. Patients with the history of CAD, CABG and/or angioplasty
2. Hb < 10 g% (in both male and female)
3. Patient with decompensated heart failure
4. Patients with metabolic syndrome
5. History of chronic kidney disease
6. History of malignancy
7. History of psychiatric illness
8. History of chronic hepatic disease
9. History of bleeding diathesis
10. Pregnancy and lactation
11. Any other medication that might effects of study drugs eg: rifampicin, phenytoin,
carbamazepine
12. Any other medical condition that, in the opinion of the investigator, may be an
unacceptable additional risk to the patient
13. Patients on antithrombotic agents including antiplatelet drugs, anticoagulants and
thrombolytic drugs for any other reason
14. Patients with history of CVA, TIA, acute or chronic pulmonary embolism or any valvular
heart disease for which he/she was on antithrombotic, anticoagulants and antiplatelet
drugs
15. Patientâ??s participation in any other clinical trial with an investigational treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method